期刊文献+

液相色谱-串联质谱法测定人血浆中左旋多巴的浓度 被引量:2

Determination of levodopa concentration in human plasma by LC-MS/MS
原文传递
导出
摘要 目的建立测定人血浆中左旋多巴浓度的液相色谱-串联质谱方法。方法采用Agilent公司Eclipse XDB-C18(4.6 mm×150 mm,5μm)色谱柱,流动相为水-甲醇(92∶8,V/V),流速为0.8 mL.min-1;电喷雾(ESI)离子源,正离子电离模式,多反应离子监测的MS扫描方式,左旋多巴和内标的离子通道分别选择为m/z 198.1→m/z 152.0和m/z 154.1→m/z 137.0。每个样品分析时间为3 min。结果左旋多巴在0.01~5 mg.L-1浓度范围内有良好的线性关系,最低定量限为0.01 mg.L-1,日内、日间RSD均小于15%,准确度均在±15%范围内。结论本方法简单、快速、灵敏、准确,可用于人血浆中左旋多巴浓度的检测。 AIM To develop a sensitive and fast liquid chromatography-tandem mass spectrometry method for the determination of levodopa concentration in human plasma. METHODS The column was Eclipse XDB-C18 (4.6 mm×150 mm,5μm), the mobile phase consisted of water : methanol (92 : 8, F/V) and the flow rate was 0.8 mL.min-1. ESI and MRM were used for MS with positive ionization model. The mass transition pairs of m/z 198.1→m/z 152.0 and m/z 154.1→m/z 137.0 were used to detect levodopa and internal standard, respectively. The running time was 3 rain. RESULTS The standard curve of levodopa was linear over the concentration range of 0.01 - 5 mg.L-1. The limit of quantitation of levodopa was 0.01 mg.L-1. Within-day RSD and between-day RSD of levodopa were all less than 15% and the accuracy were all within ± 15%. CONCLUSION The method is simple, fast, sensitive and accurate. It can be used for the determination of levodopa in human plasma.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2010年第5期365-368,共4页 Chinese Journal of New Drugs and Clinical Remedies
关键词 左旋多巴 色谱法 高压液相 光谱法 质量 电喷雾电离 多巴胺 levodopa chromatography, high pressure liquid spectrometry, mass, electrospray ionization dopamine
  • 相关文献

参考文献6

二级参考文献16

  • 1于民,张扬达.左旋多巴治疗并发症的研究进展及治疗对策[J].国外医学(神经病学.神经外科学分册),1996,23(5):233-236. 被引量:2
  • 2Nutt JG.On-off phenomenon:relation to levodopa pharmacokinetics and pharmacodynamics[J].Ann Neurol,1987,22:535-540.
  • 3Tolokan A,Klebovich I,Balogh-Nemes K,et al.Automated determination of levodopa and carbidopa in plasma by high-performance liquid chromatography-electrochemical detection using an on-line flow injection analysis sample pretreatment unit[J].J Chromatogr B Biomed Sci Appl,1997,698(1-2):201-207.
  • 4Schimiet RF,Thew G.Human physiology,springer-verlay,Berlin Heiderg[Z].New York,1983,681.Albert J S. Physiopathology of the cardiovascular system.Little Brown and company Boston/Toronto.
  • 5Yeh KC,August TF,et al.Pharmacokinetics and bioavailability of Sinemet CR:A summary of human studies[J].Neurology 39(Suppl 2),1989,11:25-37.
  • 6[1]Metman LV,Hoff J,Mouradian MM,et al.Fluctuations in plasma le vodopa a nd motor responses with liquid and tablet levodopa/carbidopa[J].Mov Disord ,1994,9(4)∶463-465.
  • 7[2]Hyland K,Clayton PT.Aromatic L-amino acid decarboxylase deficiency:diagn ostic methodology[J].Clin Chem,1992,38(12)∶2405-2410.
  • 8[3]Dethy S,Laute MA,Blercom NV,et al.Microdialysis-HPLC for plasma levo dopa and metabolites monitoring in parkinsonian patients[J].Clin Chem,1997 ,43(5)∶740-744.
  • 9[4]Blandini F,Martignoni E,Pacchetti C,et al.Simultaneous determination of L-dopa and 3-O-methyldopa in human platelets and plasma using high-perfor mance liquid chromatography with electrochemical detection[J].J Chromatogr B ,1997,700∶278-282.
  • 10中国药典.二部,2000年,109页

共引文献17

同被引文献18

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部